Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Dual Action of the PN159/KLAL/MAP Peptide: Increase of Drug Penetration across Caco-2 Intestinal Barrier Model by Modulation of Tight Junctions and Plasma Membrane Permeability.

Bocsik A, Gróf I, Kiss L, Ötvös F, Zsíros O, Daruka L, Fülöp L, Vastag M, Kittel Á, Imre N, Martinek TA, Pál C, Szabó-Révész P, Deli MA.

Pharmaceutics. 2019 Feb 10;11(2). pii: E73. doi: 10.3390/pharmaceutics11020073.

2.

Mechanisms Associated with Type 2 Diabetes as a Risk Factor for Alzheimer-Related Pathology.

Su M, Naderi K, Samson N, Youssef I, Fülöp L, Bozso Z, Laroche S, Delatour B, Davis S.

Mol Neurobiol. 2019 Jan 25. doi: 10.1007/s12035-019-1475-8. [Epub ahead of print]

PMID:
30684218
3.

Key Peptides and Proteins in Alzheimer's Disease.

Penke B, Bogár F, Paragi G, Gera J, Fülöp L.

Curr Protein Pept Sci. 2019 Jan 3. doi: 10.2174/1389203720666190103123434. [Epub ahead of print]

PMID:
30605056
4.

Structural Optimization of Foldamer-Dendrimer Conjugates as Multivalent Agents against the Toxic Effects of Amyloid Beta Oligomers.

Bartus É, Olajos G, Schuster I, Bozsó Z, Deli MA, Veszelka S, Walter FR, Datki Z, Szakonyi Z, Martinek TA, Fülöp L.

Molecules. 2018 Oct 2;23(10). pii: E2523. doi: 10.3390/molecules23102523.

5.

Searching for improved mimetic peptides inhibitors preventing conformational transition of amyloid-β42 monomer.

Gera J, Szögi T, Bozsó Z, Fülöp L, Barrera EE, Rodriguez AM, Méndez L, Delpiccolo CML, Mata EG, Cioffi F, Broersen K, Paragi G, Enriz RD.

Bioorg Chem. 2018 Dec;81:211-221. doi: 10.1016/j.bioorg.2018.08.018. Epub 2018 Aug 18.

PMID:
30144634
6.

Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.

Mészáros M, Porkoláb G, Kiss L, Pilbat AM, Kóta Z, Kupihár Z, Kéri A, Galbács G, Siklós L, Tóth A, Fülöp L, Csete M, Sipos Á, Hülper P, Sipos P, Páli T, Rákhely G, Szabó-Révész P, Deli MA, Veszelka S.

Eur J Pharm Sci. 2018 Oct 15;123:228-240. doi: 10.1016/j.ejps.2018.07.042. Epub 2018 Jul 20.

PMID:
30031862
7.

Peripheral cyclic β-amino acids balance the stability and edge-protection of β-sandwiches.

Olajos G, Hetényi A, Wéber E, Szögi T, Fülöp L, Martinek TA.

Org Biomol Chem. 2018 Aug 1;16(30):5492-5499. doi: 10.1039/c8ob01322e.

PMID:
30024580
8.

Exceptional in vivo catabolism of neurodegeneration-related aggregates.

Datki Z, Olah Z, Hortobagyi T, Macsai L, Zsuga K, Fulop L, Bozso Z, Galik B, Acs E, Foldi A, Szarvas A, Kalman J.

Acta Neuropathol Commun. 2018 Jan 29;6(1):6. doi: 10.1186/s40478-018-0507-3.

9.

GABAA receptor subunit deregulation in the hippocampus of human foetuses with Down syndrome.

Milenkovic I, Stojanovic T, Aronica E, Fülöp L, Bozsó Z, Máté Z, Yanagawa Y, Adle-Biassette H, Lubec G, Szabó G, Harkany T, Kovács GG, Keimpema E.

Brain Struct Funct. 2018 Apr;223(3):1501-1518. doi: 10.1007/s00429-017-1563-3. Epub 2017 Nov 22.

10.

Studies for Improving a Rat Model of Alzheimer's Disease: Icv Administration of Well-Characterized β-Amyloid 1-42 Oligomers Induce Dysfunction in Spatial Memory.

Kasza Á, Penke B, Frank Z, Bozsó Z, Szegedi V, Hunya Á, Németh K, Kozma G, Fülöp L.

Molecules. 2017 Nov 18;22(11). pii: E2007. doi: 10.3390/molecules22112007.

11.

β-Amyloid and the Pathomechanisms of Alzheimer's Disease: A Comprehensive View.

Penke B, Bogár F, Fülöp L.

Molecules. 2017 Oct 10;22(10). pii: E1692. doi: 10.3390/molecules22101692. Review.

12.

Biotin and Glutathione Targeting of Solid Nanoparticles to Cross Human Brain Endothelial Cells.

Veszelka S, Meszaros M, Kiss L, Kota Z, Pali T, Hoyk Z, Bozso Z, Fulop L, Toth A, Rakhely G, Deli MA.

Curr Pharm Des. 2017;23(28):4198-4205. doi: 10.2174/1381612823666170727144450. Review.

PMID:
28748755
13.

The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases.

Penke B, Fulop L, Szucs M, Frecska E.

Curr Neuropharmacol. 2018;16(1):97-116. doi: 10.2174/1570159X15666170529104323. Review.

14.

Multivalent foldamer-based affinity assay for selective recognition of Aβ oligomers.

Olajos G, Bartus É, Schuster I, Lautner G, Gyurcsányi RE, Szögi T, Fülöp L, Martinek TA.

Anal Chim Acta. 2017 Apr 1;960:131-137. doi: 10.1016/j.aca.2017.01.013. Epub 2017 Jan 24.

PMID:
28193356
15.

Reversible Opening of Intercellular Junctions of Intestinal Epithelial and Brain Endothelial Cells With Tight Junction Modulator Peptides.

Bocsik A, Walter FR, Gyebrovszki A, Fülöp L, Blasig I, Dabrowski S, Ötvös F, Tóth A, Rákhely G, Veszelka S, Vastag M, Szabó-Révész P, Deli MA.

J Pharm Sci. 2016 Feb;105(2):754-765. doi: 10.1016/j.xphs.2015.11.018.

PMID:
26869428
16.

New small-size peptides modulators of the exosite of BACE1 obtained from a structure-based design.

Gutierrez LJ, Angelina E, Gyebrovszki A, Fülöp L, Peruchena N, Baldoni HA, Penke B, Enriz RD.

J Biomol Struct Dyn. 2017 Feb;35(2):413-426. doi: 10.1080/07391102.2016.1145143. Epub 2016 Mar 8.

PMID:
26813690
17.

Protein Folding and Misfolding, Endoplasmic Reticulum Stress in Neurodegenerative Diseases: in Trace of Novel Drug Targets.

Penke B, Bogár F, Fülöp L.

Curr Protein Pept Sci. 2016;17(2):169-82. Review.

PMID:
26521955
18.

Amyloid-like Fibril Formation by Trypsin in Aqueous Ethanol. Inhibition of Fibrillation by PEG.

Kotormán M, Simon ML, Borics A, Szabó MR, Szabó K, Szögi T, Fülöp L.

Protein Pept Lett. 2015;22(12):1104-10.

PMID:
26428300
19.

Acute intracerebral treatment with amyloid-beta (1-42) alters the profile of neuronal oscillations that accompany LTP induction and results in impaired LTP in freely behaving rats.

Kalweit AN, Yang H, Colitti-Klausnitzer J, Fülöp L, Bozsó Z, Penke B, Manahan-Vaughan D.

Front Behav Neurosci. 2015 May 6;9:103. doi: 10.3389/fnbeh.2015.00103. eCollection 2015.

20.

Amyloid-β1-42 Disrupts Synaptic Plasticity by Altering Glutamate Recycling at the Synapse.

Varga E, Juhász G, Bozsó Z, Penke B, Fülöp L, Szegedi V.

J Alzheimers Dis. 2015;45(2):449-56. doi: 10.3233/JAD-142367.

PMID:
25547631

Supplemental Content

Loading ...
Support Center